These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17976390)

  • 1. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
    Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
    Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
    Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
    Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy".
    Pacher P
    Free Radic Biol Med; 2008 Mar; 44(6):969-71. PubMed ID: 18194675
    [No Abstract]   [Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
    Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
    Drel VR; Lupachyk S; Shevalye H; Vareniuk I; Xu W; Zhang J; Delamere NA; Shahidullah M; Slusher B; Obrosova IG
    Endocrinology; 2010 Jun; 151(6):2547-55. PubMed ID: 20357221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
    Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
    Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
    Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
    Lupachyk S; Shevalye H; Maksimchyk Y; Drel VR; Obrosova IG
    Free Radic Biol Med; 2011 May; 50(10):1400-9. PubMed ID: 21300148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.
    Li F; Drel VR; Szabó C; Stevens MJ; Obrosova IG
    Diabetes; 2005 May; 54(5):1514-22. PubMed ID: 15855340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
    Nangle MR; Cotter MA; Cameron NE
    J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration.
    Hulse RP; Beazley-Long N; Ved N; Bestall SM; Riaz H; Singhal P; Ballmer Hofer K; Harper SJ; Bates DO; Donaldson LF
    Clin Sci (Lond); 2015 Oct; 129(8):741-56. PubMed ID: 26201024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
    Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
    Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
    Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibitors attenuate chemotherapy-induced painful neuropathy.
    Brederson JD; Joshi SK; Browman KE; Mikusa J; Zhong C; Gauvin D; Liu X; Shi Y; Penning TD; Shoemaker AR; Giranda VL
    J Peripher Nerv Syst; 2012 Sep; 17(3):324-30. PubMed ID: 22971094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.